The study demonstrated that patients with MS did not have an increase number of exacerbations following
influenza vaccination and the authors concluded that the
influenza vaccination is safe for most patients.
In general, while there is no contraindication to proceeding with the influenza vaccination and beginning Copaxone several weeks later, specific treatments decisions are best made by discussion your plan with your treating health care provider.
~•~ Dr.